VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $10,948,000 | -20.0% | 61,374 | -0.3% | 0.28% | -28.4% |
| Q2 2015 | $13,678,000 | +12.8% | 61,571 | +0.9% | 0.39% | +35.4% |
| Q1 2015 | $12,121,000 | +37.0% | 61,026 | -1.3% | 0.29% | +29.3% |
| Q4 2014 | $8,848,000 | +11.9% | 61,826 | +2.6% | 0.22% | +10.8% |
| Q3 2014 | $7,910,000 | +10.0% | 60,288 | +5.7% | 0.20% | +10.9% |
| Q2 2014 | $7,194,000 | -4.4% | 57,037 | -0.1% | 0.18% | -2.7% |
| Q1 2014 | $7,524,000 | +1.1% | 57,071 | -10.0% | 0.19% | -3.6% |
| Q4 2013 | $7,444,000 | +7.1% | 63,409 | -4.8% | 0.20% | 0.0% |
| Q3 2013 | $6,949,000 | +25.4% | 66,608 | +3.4% | 0.20% | +18.9% |
| Q2 2013 | $5,543,000 | – | 64,390 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |